With a budget of up to $20m, the collaboration will establish scalable, rapid manufacturing for recombinant-protein vaccines.

The host cell system is a critical determinant of recombinant protein quality and yield, with direct influence on protein folding and post-translational modification factors that shape the ...

Immobilized metal affinity chromatography (IMAC) is a reliable method for isolation of recombinant protein following over-expression in Escherichia coli. The polyhistidine tag (6–10 consecutive amino ...

Recombinant protein vaccines, which are obtained by conventional genetic engineering, are based on the proteins of target pathogens that can activate our immune systems. Unlike other types of vaccines ...

Dr. Rob Burgess shares how Sino Biological empowers global biomedical research through precision, quality, and ...

Contract development and manufacturing organization (CDMO) Samsung Biologics has partnered with the vaccine research and development foundation Coalition for Epidemic Preparedness Innovations (CEPI) ...

Focusing on the establishment of Sino Biological‘s Center for Bioprocessing (C4B) in Houston, it highlights how the ...

PRESS RELEASE Strategic research collaboration to advance MTx’s recombinant polyclonal IgG technologyAgreement includes R&D funding for exploratory work, technology access and, assuming exercise of ...

PPT1 is a recombinant protein used to treat an ultra-rare disease called Batten disease CLN1 for which there is ...

Chicago, IL – January 26, 2026 – Sino Biological US, Inc. , a global leader in recombinant proteins, antibodies, and CRO services, will be featured on Inside Business Today , hosted by Bill Rancic and ...